December 20, 2005
US health agency says China open on bird flu
BEIJING (Reuters) - China and the United States are
cooperating on efforts to understand deadly bird flu, a major
shift from Beijing's handling of SARS, U.S. National Institutes
of Health director Elias Zerhouni said on Tuesday.
"There is a definite willingness to be completely
cooperative, be completely transparent and to exchange samples
with the WHO and with other partners so we can track the
genetic changes," he told a news conference in Beijing.
before SARS, where transparency and cooperation was less than
optimal," he said. "At the time, we had a real difficulty in
collaborating, getting samples and explanations."
China was criticized widely for its initial cover-up of the
SARS virus, which first emerged in its southern province of
Guangdong in 2003.
The World Health Organization (WHO) confirmed that China
had agreed to share virus isolates from human bird flu cases,
which the U.N. agency has been seeking to help it track the
deadly H5N1 virus.
The director of the Chinese Centers for Disease Control
presented Shigeru Omi, WHO's regional director for the Western
Pacific, with a draft agreement in Beijing on Tuesday, said WHO
spokeswoman Maria Cheng.
"They agreed they would share the isolates with WHO's
network of collaborating centers," said Geneva-based Cheng,
adding details on logistics would be finalized very shortly.
Sharing virus isolates taken from human bird flu patients
will help experts track the virus to see how it changes and
allow them to compare any genetic changes with cases in
countries such as Indonesia and Vietnam.
This year, China has had more than 30 outbreaks of the
deadly H5N1 strain of bird flu that scientists fear could
mutate from a disease which largely affects birds to one that
can pass easily between people, leading to a human pandemic.
There have been 139 confirmed human cases of H5N1, all of
them in Asia, including six in China. Two people have died from
bird flu in China, out of 71 known fatalities in Asia.
The U.S. and Chinese Centers for Disease Control and
Agriculture Ministries were collaborating to build the ability
to detect and diagnose the virus and train experts, Zerhouni
Tracking changes in samples from human cases was key to
developing a vaccine and the National Institutes of Health was
working on a vaccine as well as testing antiviral medicines
that could provide an alternative to Tamiflu, he said.
(Additional reporting by Stephanie Nebehay in Geneva)